Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

RSC Energia reported for Q1 under RAS

4/17/24 RKKE

Izhstal reported for the 1st quarter by RAS

4/17/24 IGST

MTS will start production of 5G and 4G base stations by the end of the year

4/17/24 MTSS

Inter RAO builds in Kazakhstan three coal-fired CHPPs

4/17/24 IRAO

Alrosa will hold an auction of investment diamonds

4/17/24 ALRS

MTS may bring its media holding to IPO

4/17/24 MTSS

Smartofood has opened a round of investment raising

4/17/24 OTCI

Magnit will multiply the network of hard discounters

4/17/24 MGNT

MGKL launched its store on Ozon

4/17/24 MGKL

X5 Retail Group will distribute accumulated funds in favor of shareholders

4/17/24 X5